Schiff Hardin advised The Benchmark Company as managing underwriter in the transaction The shareholders of the dermatology-focused biotechnology company have pre-emptive rights under German law and…
Biofrontera AG’s $12 million American depositary shares (ADSs) Initial Public Offering
![](https://globallegalchronicle.com/wp-content/uploads/2018/04/486e7dad53-480x360.jpeg)